NCT03784989

Brief Summary

This is a post market clinical follow-up study and devices will carry the CE mark once the study is initiated. The investigational device is SenSura® Mio Kids, which is a flat ostomy device. The device is comprised by a baseplate connected to a bag. The coupling between baseplate and bag can be either welded together, referred to as a 1-piece (1P) system, or assembled as separate parts, referred to as a 2-piece (2P) system.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2019

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 24, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

April 15, 2019

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 8, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2020

Completed
Last Updated

November 17, 2022

Status Verified

November 1, 2022

Enrollment Period

1.4 years

First QC Date

December 20, 2018

Last Update Submit

November 15, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Median wear time

    of 8 baseplate changes

    2-3 weeks

Eligibility Criteria

Age6 Months - 4 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The population in this study are subjects from the age of 6 months (calculated from term age meaning 40 gestational weeks) to 4 years either with a colo-, ileo- or urostomy or a loop stoma, or two stomas placed closely together. Subjects can participate in the PMCF study if they fulfill the in-/exclusion criteria as listed in the tables below. However, the per protocol population only include 30 subjects as needed for the compara-tive performance evaluation (Group 1), and these subjects must fulfill inclusion criteria no. 3 (subjects should use a competitor device).

You may qualify if:

  • Have a colostomy, ileostomy, urostomy, loop stoma, or two stomas placed closely together
  • Have given written informed consent (the legal authorized representative of the subject)
  • Group 1 subjects should use a competitor device

You may not qualify if:

  • \) Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin (as-sessed by the investigator)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Driscoll Childrens Hospital

Corpus Christi, Texas, 78411, United States

Location
0

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2018

First Posted

December 24, 2018

Study Start

April 15, 2019

Primary Completion

September 8, 2020

Study Completion

September 8, 2020

Last Updated

November 17, 2022

Record last verified: 2022-11

Locations